Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
PolandDuchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen
PolandStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
PolandStudy of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45
PolandStudy of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment
PolandStudy on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis
PolandStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
PolandEfficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy
PolandStudy on the Safety and Effectiveness of DT-DEC01 for Patients with Duchenne Muscular Dystrophy
PolandStudy on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases
PolandStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
PolandA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
Polandpowered by
